Keyphrases
Immune Tolerance
100%
High-risk Human Papillomavirus (HR-HPV)
100%
Helminth Infection
100%
Intestinal Helminth Infections
71%
Helminths
42%
Cervical Cancer
28%
Possible Mechanisms
14%
Malignancy
14%
Virus
14%
Immunomodulation
14%
Human Studies
14%
Immunoregulation
14%
New Drug Targets
14%
Endemic Region
14%
Low-middle Income Countries
14%
Epidemiological Characteristics
14%
Papillomavirus Infections
14%
Immune Dysregulation
14%
Inflammatory Disorders
14%
High Burden
14%
Intestinal Helminths
14%
Human Immune System
14%
Tolerogenic
14%
Human Cervical Spine
14%
High Leverage
14%
High Cervical
14%
Improved Strategies
14%
Cervical Cancer Prevention
14%
Oncogenic Viruses
14%
Systemic Immune Response
14%
Cervical Cancer Incidence
14%
Immune Environment
14%
Unconventional Approaches
14%
Resource-constrained
14%
Constrained Region
14%
Fertile Soil
14%
Medicine and Dentistry
Gut
100%
Wart Virus
100%
Immunological Tolerance
100%
Helminthiasis
100%
Cervical Cancer
57%
Helminth
57%
Disease
14%
Cancer Incidence
14%
Malignant Neoplasm
14%
Cancer
14%
Human Study
14%
Immunoregulation
14%
Inflammatory Disorder
14%
Immune System
14%
Low and Middle Income Countries
14%
Immunomodulation
14%
Papillomavirus Infection
14%
Cancer Control
14%
Tumor Virus
14%
Immune Dysregulation
14%
Pharmacology, Toxicology and Pharmaceutical Science
Human Papillomavirus
100%
Helminthiasis
100%
Uterine Cervix Cancer
57%
Helminth
57%
Disease
28%
Malignant Neoplasm
14%
Immunomodulation
14%
Human Study
14%
Cancer Incidence
14%
Papillomavirus Infection
14%
Tumor Virus
14%
Immune Dysregulation
14%
Immunology and Microbiology
Immune Tolerance
100%
Wart Virus
100%
Helminthiasis
100%
Helminth
50%
Immunomodulation
12%
Immune System
12%
Immunoregulation
12%
Inflammatory Disorder
12%
Immune Dysregulation
12%
Oncovirus
12%
Cancer Incidence
12%